As of 2024-11-03, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -6.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 291.23 mil USD. AVITA's TTM EBITDA according to its financial statements is -44.70 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 7.9x - 15.1x | 11.4x |
Forward P/E multiples | 12.8x - 17.6x | 16.1x |
Fair Price | (22.95) - (26.91) | (24.60) |
Upside | -322.8% - -361.2% | -338.8% |
Date | EV/EBITDA |
2024-10-28 | -6.64 |
2024-10-25 | -6.42 |
2024-10-24 | -6.42 |
2024-10-23 | -6.57 |
2024-10-22 | -6.71 |
2024-10-21 | -6.64 |
2024-10-18 | -6.71 |
2024-10-17 | -6.61 |
2024-10-16 | -6.74 |
2024-10-15 | -6.59 |
2024-10-14 | -6.58 |
2024-10-11 | -6.52 |
2024-10-10 | -6.28 |
2024-10-09 | -6.41 |
2024-10-08 | -6.42 |
2024-10-07 | -6.61 |
2024-10-04 | -6.82 |
2024-10-03 | -6.80 |
2024-10-02 | -6.93 |
2024-10-01 | -6.66 |
2024-09-30 | -6.76 |
2024-09-27 | -6.77 |
2024-09-26 | -6.68 |
2024-09-25 | -6.58 |
2024-09-24 | -6.67 |
2024-09-23 | -6.67 |
2024-09-20 | -6.85 |
2024-09-19 | -6.82 |
2024-09-18 | -6.59 |
2024-09-17 | -6.49 |
2024-09-16 | -6.49 |
2024-09-13 | -6.49 |
2024-09-12 | -6.17 |
2024-09-11 | -6.09 |
2024-09-10 | -5.99 |
2024-09-09 | -5.80 |
2024-09-06 | -5.67 |
2024-09-05 | -5.70 |
2024-09-04 | -5.77 |
2024-09-03 | -5.52 |
2024-08-30 | -5.97 |
2024-08-29 | -5.82 |
2024-08-28 | -5.82 |
2024-08-27 | -5.85 |
2024-08-26 | -5.99 |
2024-08-23 | -5.96 |
2024-08-22 | -5.63 |
2024-08-21 | -5.89 |
2024-08-20 | -5.68 |
2024-08-19 | -5.81 |